Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Piper Sandler Downgrades Livongo Health to Neutral, Raises Price Target to $143

Author: Benzinga Newsdesk | October 28, 2020 05:22am
Piper Sandler analyst Sean Wieland downgrades Livongo Health (NASDAQ:LVGO) from Overweight to Neutral and raises the price target from $55 to $143.

Posted In: LVGO